HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of cardiovascular risk in women who had hypertension during pregnancy after 36 weeks gestation.

AbstractOBJECTIVE:
To analyse preventive interventions of women with cardiovascular risk factors postpartum.
METHODS:
3.5 years postpartum, women with history of hypertension in pregnancy were invited for a questionnaire, 1 year after a cardiovascular risk assessment.
RESULTS:
Two hundred and fifty-seven women completed the questionnaire. At risk factor analyses, 35% had hypertension, 37% abnormal lipid- or glucose levels, 63% BMI ≥ 25 and 19% smoked. One year later, 36% of women with hypertension used anti-hypertensives, 0% of women with abnormal laboratory findings used anti-cholesterol and 1% anti-diabetes medication, 31% of the obese women achieved BMI reduction (≥ 5%), 42% of the women who smoked, quit.
CONCLUSION:
A minority improved their risk profile.
AuthorsFloortje van Kesteren, Sanne Visser, Wietske Hermes, Arie Franx, Maria G van Pampus, Mireille N M Poppel, Jouke T Tamsma, Ben W Mol, Christianne J de Groot
JournalHypertension in pregnancy (Hypertens Pregnancy) Vol. 34 Issue 2 Pg. 261-9 (May 2015) ISSN: 1525-6065 [Electronic] England
PMID25815424 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
Topics
  • Antihypertensive Agents (therapeutic use)
  • Cardiovascular Diseases (epidemiology, prevention & control)
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Hypertension, Pregnancy-Induced (drug therapy, epidemiology)
  • Obesity (complications)
  • Postpartum Period (blood)
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior
  • Surveys and Questionnaires

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: